Neil has particular interest and expertise in the management and conduct of cross-border patent litigation.
Neil is a partner in the intellectual property group based in London. He joined the firm in 1986 and became a partner in 1996.
His current practice is focused on patent litigation in the life science field but he also advises on such related matters as regulatory data exclusivity and supplementary protection certificates.
His more high profile cases, before the English Courts and in the CFI include PLG v Ardon (plastic grids), ICI v Montedison (polymer composite), HCC v BP (acetic acid purification), UCC v BP (fluid bed production of polyethylene), Stephenson v Du Pont (entitlement), Hesco v Maccaferri (gabions), Chef Revival v OHIM (Chef mark), Agilent v Waters (HPLC pumps), Teva v Merck (alendronate), Teva v Merck (simvastatin), Lundbeck v Niche (citalopram), Abbott v APS (clarithromycin), Celltech v OHIM (Celltech mark), Actavis v Merck (finasteride), Actavis v Novartis (fluvastatin), Specialty Brands v OHIM (Dog Device), Teva v Merck (timolol/dorzolamide combination), Generics v Yeda/Teva (Copaxone) and Teva v Amgen (lipegfilgrastim).
Neil speaks regularly at IP conferences and contributes to the leading IP journals on many aspects of IP law and litigation as well as being the editor of International Intellectual Property Litigation (published by Butterworths). He is a member of the IPO international patent law and practice committee, the INTA publications sub-committee and the CIPA litigation sub-committee.
Chambers UK (2015) quotes sources who say, "He's very experienced and very thorough – really knows his stuff.”
This biography is an extract from Who's Who Legal: Life Sciences which can be purchased from our Shop.
Neil Jenkins also features in the following practice areas:
It is not possible to buy entry into any Who's Who Legal publication
Nominees have been selected based upon comprehensive, independent survey work with both general counsel and private practice lawyers worldwide. Only specialists who have met independent international research criteria are listed.